Mingyi Chen, M.D., Ph.D.

Specialties

Pathology - Molecular

Pathology - Hematopathology

Title

  • Associate Professor
To see if Mingyi Chen is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

Pathology Building

4400 V St.
Sacramento, CA 95817
Driving Directions

Primary Phone:
916-734-2525

Additional Phone Numbers

Physician Referrals: 800-4-UCDAVIS (800-482-3284)

Clinical Interests

Dr. Chen's clinical interests include: Hematopathology- lymphoma, leukemia, flow cytometry, bone marrow  transplant and diagnostic molecular pathology, Pulmonary pathology, and GI-liver pathology.

 

Research/Academic Interests

Dr. Chen's research interests include: Sickle cell disease, thrombosis, and vascular biology, Molecular pathogenesis of lymphoma and leukemia, tumor immunology and GVHD, Viral infections and cancergenesis.

Division

Anatomic Pathology

Center/Program Affiliation

UC Davis Medical Group

Education

M.D., Peking University Health Science Center, Beijing, China 1992

Ph.D., Kyoto University, Kyoto Japan 2001

Residency

Pathology and Lab Medicine, Loma Linda University Hospital, Loma Linda CA 2009

Fellowships

Pathology, City of Hope Medical Center, Duate CA 2010

Board Certifications

American Board of Pathology, Anatomic and Clinical Pathology,

American Board of Pathology, Hematology,

Professional Memberships

American Society of Hematology

International Society for Laboratory Hematology

United States and Canadian Academy of Pathology

Honors and Awards

International Society Hematology Presentation Award, 2014

Faculty Teaching Award of Department of Pathology UC Davis Medical Center, 2013

Select Recent Publications

Mirsoian A, Boucklaka MN, Sckisel GD, Chen M, Pai CS, Maverakis,E, Spencer RG. Fishbein KF, Siddiqui S, Monjazeb AM, Martin B, Maudsley S, Longo DL, Blazar BR, Taub DD, and Murphy WJ. Adiposity as a Principal Component of Lethal Cytokine Storm Following Immunotherapy in Aged Mice. J Exp Med. 2014 Nov 17;211(12):2373-83.

Canter RJ, Ames E, Mac S, Grossenbacher SK, Chen M, Li CS, Borys D, Smith RC, Tellez J, Sayers TJ, Monjazeb AM, Murphy WJ. Anti-Proliferative but not Anti-Angiogenic Tyrosine Kinase Inhibitors Enrich for Cancer Stem Cells in Soft Tissue Sarcoma. BMC Cancer 2014 Oct 10;14(1):756.

Pai CC, Chen M, Mirsoian A, Grossenbacher SK, Tellez J, Ames E, Sun K, Blazar BR, Murphy WJ, Mehrdad A. Treatment of Chronic Graft versus Host Disease with Bortezomib. Blood. 2014 Sep 4;124(10):1677-88.

Pai CC, Hsiao HH, Sun K, Chen M, Hagino T, Tellez J, Mall C, Blazar BR, Monjazeb A, Abedi M, Murphy WJ. Therapeutic benefit of bortezomib on acute GVHD is tissue specific and is associated with IL-6 levels. Biol Blood Marrow Transplant. 2014 Jul 23. pii: S1083-8791(14)00448-50.

Alvarez M, Bouchlaka MN, Sckisel GD, Sungur CM, Chen M, Murphy WJ. J Immunol. 2014 Jul 7. pii: 1400034. Increased Antitumor Effects Using IL-2 with Anti-TGF-β Reveals Competition between Mouse NK and CD8 T Cells. J Immunol. 2014 Aug 15;193(4):1709-16.

Chen M, Abedi M. Atypical lymphocytosis and cold agglutinin hemolytic anemia associated with monoclonal gammopathy in HIV-infected patient with marrow involvement by diffuse large B-cell lymphoma. Blood, 2013 Nov 28;122(23):3711.

 

Chen M, Green R. Circulating plasma cells with Russell bodies in osteroslerotic myeloma. Blood 2013 122:160

Chen M, Olson K. Colonic graft-versus-host disease (GVHD) manifesting as eosinophilic colitis following autologous hematopoietic stem cell transplantation. Blood. 2013 May 16;121(20):4020.

 

Sungur CM, Tang-Feldman YJ, Ames E, Alvarez M, Chen M, Longo DL, Pomeroy C, Murphy WJ. Murine natural killer cell licensing and regulation by T regulatory cells in viral responses. Proc Natl Acad Sci U S A. 2013 Apr 30;110(18):7401-6.

 

Bouchlaka M Sckisel G, Chen M,, Mirsoan A, Zamora A, Monjazeb A, Longo D, Blazar BR, Taub DD,  Murphy WJ. Aging Predisposes to Acute Pro-inflammatory Cytokine Storm-Induced Pathologies Following Systemic Immune Stimulation. J Exp Med. 2013 Oct 21;210(11):2223-37.